https://www.who.int/health-topics/drugs-psychoactive
Jun 25, 2024 · The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug us
https://www.who.int/our-work/access-to-medicines-and-health-products/who-drug-information
About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide
https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive
Jan 1, 2015 · The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies
https://www.who.int/tools/atc-ddd-toolkit/atc-classification
In the Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and t
https://www.who.int/news/item/09-02-2025-who-updates-guidelines-on-opioid-dependence-treatment-and-overdose-prevention
Feb 9, 2025 · WHO announces development of updated guidelines for the psychosocially assisted pharmacological treatment of opioid dependence and community management of opioid …
https://www.who.int/health-topics/medicines
Access to appropriate medications is shown to have substantial impacts on community health and the related economic indicators. Quality-assured, safe and effective medicines, vacci
https://www.who.int/news/item/13-10-2025-who-warns-of-widespread-resistance-to-common-antibiotics-worldwide
Oct 13, 2025 · One in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to antibiotic treatments, according to a n
https://www.who.int/news/item/14-07-2025-who-recommends-injectable-lenacapavir-for-hiv-prevention
Jul 14, 2025 · The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre …
https://www.who.int/publications/i/item/9789240107243
Apr 15, 2025 · Module 4: treatment and care encompass all current recommendations for managing drug-susceptible and drug-resistant TB, alongside patient care and support …
https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025/tb-disease-burden/1-3-drug-resistant-tb
1.3 Drug-resistant TBTrends at regional level vary (Fig. 1.3.3). Between 2020 and 2024, there were estimated increases in the number of people who developed MDR/RR-TB in the WHO â€